EUSA Pharma Announces New QARZIBA®▼ (Dinutuximab beta) Data to Be Presented at 2019 ASCO Annual Meeting

BOSTON and HEMEL HEMPSTED, England, May 29, 2019 /PRNewswire/ -- EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announces that the Principal Investigators from two studies of QARZIBA®▼ (dinutuximab beta)1,2 in the treatment of high-risk...

from PR Newswire: https://prn.to/2YRmKoI